Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Congress 2024

Next generation of combinations in early clinical trials

How to exploit radiation-induced tumour microenvironment vulnerabilities?

Date

15 Sep 2024

Session

Next generation of combinations in early clinical trials

Topics

Tumour Immunology;  Translational Research;  Immunotherapy;  Radiation Oncology

Tumour Site

Presenters

Fernanda Herrera

Authors

F. Herrera

Author affiliations

  • Immuno-oncology Department, CHUV - Centre Hospitalier Universitaire Vaudois, 1011 - Lausanne/CH

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

DDR inhibitor combinations

Presenter: Timothy Anthony Yap

Session: Next generation of combinations in early clinical trials

Resources:

Slides

Webcast

Q&A and discussion

Session: Next generation of combinations in early clinical trials

Resources:

Webcast

Conclusions and perspectives

Presenter: Elena Garralda

Session: Next generation of combinations in early clinical trials

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.